Clinical Treatment of Refractory Breast Cancer Based on Organoid Drug Sensitivity Results
Clinical trial NCT06438055 · UNKNOWN
Trial details
- NCT number
- NCT06438055
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-01
- Primary completion
- 2025-06-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.